BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 27
• 28
• 29
• 30

• Genetown

  Lysosomal Therapeutics Inc. Receives $4.8 Million In Seed Funding

  May 12, 2014

   · 

  1 min read
• Drug Development

  Alnylam Pharmaceuticals Announces New RNAi Therapeutic Program For The Treatment Of Hepatitis B Virus (HBV) Infection And Reports An Up To 2.3 Log10 Reduction Of HBV Surface Antigen (HBsAg) In Chronically Infected Chimpanzees

  May 12, 2014

   · 

  1 min read
• Business

  Ligand Pharmaceuticals Inc. Earns Milestone From SAGE Therapeutics For SAGE-547

  May 12, 2014

   · 

  1 min read
• Genetown

  Harvard Apparatus Regenerative Technology CEO David Green Interviewed On Boston’s CBS-TV Affiliate On May 8

  May 12, 2014

   · 

  1 min read
• Report On Transactions With ALK-Abello A/S B-Shares And Associated Securities By Managerial Staff

  May 12, 2014

   · 

  1 min read
• Business

  Repros Therapeutics Inc. Reports First Quarter 2014 Financial Results

  May 12, 2014

   · 

  1 min read
• Bruker Corporation Introduces Beta-Lactamase Testing, New Productivity Software Modules, As Well As MBT Pilot And MBT Galaxy Accessories For MALDI Biotyper

  May 12, 2014

   · 

  1 min read
• Rafarma Pharmaceuticals Commences Preparation Of Audited Financials

  May 12, 2014

   · 

  1 min read
• Bruker Corporation Release: New MRI CryoProbe™ Delivers Highest Sensitivity In Rat Brain In vivo Imaging

  May 12, 2014

   · 

  1 min read
• Drug Development

  Novavax, Inc. Release: One Year Follow-Up From RSV F-Protein Vaccine Candidate Phase 1 Elderly Trial Demonstrates Sustained Levels Of Immune Response

  May 12, 2014

   · 

  1 min read